Epigenomics AG Reports Third Quarter 2006 Results

November 2, 2006 |

1 min read

BERLIN and SEATTLE, Nov. 2, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial results for the third quarter ending September 30, 2006.

Earnings Europe

MORE ON THIS TOPIC

Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.

Funding

Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design

March 23, 2026

·

2 min read

·

Tristan Manalac

Brain neuro cell growth or damaging drawing with texture shading illustration isolated on dark background

Parkinson’s disease

Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy

March 23, 2026

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Gossamer, BiomX Reveal Hefty Staff Cuts

March 20, 2026

·

39 min read

·

BioSpace Editorial Staff

Iranian flag against a burning sky

Policy

Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets

March 20, 2026

·

2 min read

·

Annalee Armstrong